ULGX Financials Monday, July 14, 2014 11:16:31 PM

ULGX Financials Monday, July 14, 2014 11:16:31 PM
Urologix, Inc.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 16,590 17,027 12,571 14,771
Cost of Revenue 8,407 8,645 6,030 6,569
Gross Profit 8,183 8,382 6,541 8,202
Operating Expenses
Research and Development 2,269 2,189 2,238 1,834
Sales, General and Admin. 9,893 10,248 8,005 8,601
Non-Recurring Items 160 - - -
Other 104 90 24 24
Operating Income (3,922) (4,145) (3,726) (2,257)
Income From Continuing Operations
Add'l Income/Expense Items 520 (13) - -
Earnings Before Interest and Tax (4,278) (4,640) (3,725) (2,257)
Interest Expense - - - -
Earnings Before Tax (4,278) (4,640) (3,725) (2,257)
Income Tax 14 55 8 (88)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,086) (4,695) (3,733) (2,169)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,292) (4,695) (3,733) (2,169)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,292) (4,695) (3,733) (2,169)